Ipsen
China - Tianjin
BiotechnologyFocus: Small Molecules, Biologics
Ipsen is a life sciences company focused on Small Molecules, Biologics.
OncologyEndocrinologyNeurologyGastroenterologyMetabolic Diseases
Employees
1001-5000
Open Jobs
0
Products & Portfolio (7)
2 discontinued products not shown
BYLVAY
odevixibat
Peak
ORAL · CAPSULE
Ileal Bile Acid Transporter Inhibitors
pruritus in patients 3 months of ageolder with PFICcholestatic pruritus in patients 12 months of age+1 more
2021
0
DYSPORT
botulinum toxin type a
LOE Approaching
INJECTION · INJECTABLE
Acetylcholine Release Inhibitors
cervical dystonia in adultsspasticity in patients 2 years of ageolder
2009
30
INCRELEX
mecasermin
LOE Approaching
SUBCUTANEOUS · INJECTABLE
Insulin-like growth factor-1 (IGF-1) is a key hormonal mediator on statural growth. Under normal circumstances, growth hormone (GH) binds to its receptor in the liver, and other tissues, and stimulates the synthesis/secretion of IGF-1. In target tissues, the Type 1 IGF-1 receptor, which is homologous to the insulin receptor, is activated by IGF-1, leading to intracellular signaling which stimulates multiple processes resulting in statural growth. The metabolic actions of IGF-1 are in part directed at stimulating the uptake of glucose, fatty acids, and amino acids so that metabolism supports growing tissues.
growth failure in pediatric patients 2 years of ageolder with severe primary IGF-1 deficiencygrowth hormone (GH) gene deletion+1 more
2005
30
IQIRVO
elafibranor
Growth
ORAL · TABLET
Peroxisome Proliferator-activated Receptor Agonists
2024
0
ONIVYDE
irinotecan hydrochloride
Peak
INTRAVENOUS · INJECTABLE, LIPOSOMAL
1 inhibitor encapsulated in a lipid bilayer vesicle or liposome. Topoisomerase 1 relieves torsional strain in DNA by inducing single-strand breaks. Irinotecan and its active metabolite SN-38 bind reversibly to the topoisomerase 1-DNA complex and prevent re-ligation of the single-strand breaks, leading to exposure time-dependent double-strand DNA damage and cell death. In mice bearing human tumor xenografts, irinotecan liposome administered at irinotecan HCl-equivalent doses 5-fold lower than irinotecan HCl achieved similar intratumoral exposure of SN-38.
2015
0
SOHONOS
palovarotene
Growth
ORAL · CAPSULE
FOP, abnormal bone formation, including heterotopic ossification (HO), is driven by a gain-of-function mutation in the bone morphogenetic protein (BMP) type I receptor ALK2 (ACVR1). Palovarotene is an orally bioavailable retinoic acid receptor agonist, with particular selectivity at the gamma subtype of RAR. Through binding to RARγ, palovarotene decreases the BMP/ALK2 downstream signaling pathway by inhibiting the phosphorylation of SMAD1/5/8, which reduces ALK2/SMAD-dependent chondrogenesis and osteocyte differentiation resulting in reduced endochondral bone formation.
2023
0
SOMATULINE DEPOT
lanreotide acetate
LOE Approaching
PeptideSUBCUTANEOUS · SOLUTION
2007
30
Pipeline & Clinical Trials
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptor
Prostate CancerClinical Trials (1)
NCT04593420Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
N/AStudy of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or M
Advanced Renal Cell CarcinomaClinical Trials (1)
NCT03647878Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
N/ASomatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
AcromegalyClinical Trials (1)
NCT00686348Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
N/ABotulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke
Upper Limb Spasticity Post-StrokeClinical Trials (1)
NCT02384330Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke
N/AAdult Subjects Suffering From Lower Limb Spasticity Following Stroke
SpasticityClinical Trials (1)
NCT01444794Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
N/ADescription of Sign-and-symptom Associations at Acromegaly Diagnosis.
AcromegalyClinical Trials (1)
NCT02012127Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
N/ABotulinum toxin type A
Lower Limb SpasticityClinical Trials (1)
NCT02020980RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke
N/AStudy to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real
Adult Lower Limb SpasticityClinical Trials (1)
NCT04050527Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
N/AIGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
IGF-1 DeficiencyClinical Trials (1)
NCT01676090IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
N/APost-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Renal Cell CarcinomaClinical Trials (1)
NCT03776123Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
N/AA Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Fam
Progressive Familial Intrahepatic CholestasisClinical Trials (1)
NCT07185919A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea
N/AData collection
Ulcerative ColitisClinical Trials (1)
NCT03689673Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)
N/AA Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, Grip
Upper Limb Spasticity (ULS)Clinical Trials (1)
NCT05169775A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).
N/APatient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromega
AcromegalyClinical Trials (1)
NCT05184231Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China
N/AA Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for H
Neuroendocrine TumorsClinical Trials (1)
NCT01234168A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
N/ALongitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients
Cervical DystoniaClinical Trials (1)
NCT01840462Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]
N/ASomatuline Autogel® 60, 90 or 120 mg
AcromegalyClinical Trials (1)
NCT01840449Somatuline Predictive Factors in Acromegaly and NET
N/AAttainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real
Upper Limb SpasticityClinical Trials (1)
NCT02454803Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
N/AThis is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.
Gastroenteropancreatic Neuroendocrine TumorsClinical Trials (1)
NCT02630654Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs
N/AData collection
Spasticity, MuscleClinical Trials (1)
NCT03442660Validation of the Spasticity Related Quality of Life Questionnaire
N/Aplatinum chemotherapy
Neuroendocrine TumorsClinical Trials (1)
NCT04365023Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
N/ASAGIT
AcromegalyClinical Trials (1)
NCT02231593SAGIT for Classification of Patients With Acromegaly in Clinical Practice
N/APredictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Dis
AcromegalyClinical Trials (1)
NCT00500227Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
N/ATazemetostat
Epithelioid Sarcoma (Ex-US Only)Clinical Trials (1)
NCT03874455Tazemetostat Expanded Access Program for Adults With Solid Tumors
N/AAbobotulinum toxin A
Tourette SyndromeClinical Trials (1)
NCT02187679Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome
N/AData collection
Internal EndometriosisClinical Trials (1)
NCT03586063Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis
N/AEziclen®/Izinova®
Bowel CleansingClinical Trials (1)
NCT02630680Eziclen Drug Utilisation in Real Life Setting
N/ANon-interventional cross-sectional survey
AcromegalyClinical Trials (1)
NCT02020967Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
N/Amecasermin [rDNA origin] injection
Primary Insulin-like Growth Factor-1 DeficiencyClinical Trials (1)
NCT00747604IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex
N/AReal-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in
AcromegalyClinical Trials (1)
NCT05431803Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
N/AStudy of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therap
Follicular LymphomaClinical Trials (1)
NCT07282548Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
N/ATriptorelin Acetate 3.75mg intramuscular injection
Deep Infiltrating Endometriosis (DIE)Clinical Trials (1)
NCT01942369A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months
N/AOdevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixiba
Pregnancy RelatedClinical Trials (1)
NCT06258902Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
N/ARetrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In
SpasticityClinical Trials (1)
NCT04446702Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA
N/AA Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Pa
Fibrodysplasia Ossificans ProgressivaClinical Trials (1)
NCT06089616A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
N/AA Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrah
PFIC - Progressive Familial Intrahepatic CholestasisClinical Trials (1)
NCT07191704A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain
N/ATherapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
AcromegalyClinical Trials (1)
NCT02698384Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
N/AQuality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroen
Gastrointestinal Neuroendocrine TumoursClinical Trials (1)
NCT02853422Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
N/ACARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients
Upper Limb InjuryClinical Trials (1)
NCT06245772CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
N/AQuality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
Prostate CancerClinical Trials (1)
NCT02853409Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
N/AN/A
Clinical Trials (1)
NCT04624828Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT
N/ACabozantinib monotherapy
Locally Advanced or Metastatic Renal Cell CarcinomaClinical Trials (1)
NCT04353765Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
N/AA Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in
Advanced Renal Cell CarcinomaClinical Trials (1)
NCT03696407A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK
N/AUnited Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Sett
Neuroendocrine Tumours (NET)Clinical Trials (1)
NCT04649580United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting
N/AA Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrin
Neuroendocrine TumorsClinical Trials (1)
NCT05922579A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
N/ADYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
Cervical DystoniaClinical Trials (1)
NCT01314365DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
N/AA Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real
Spasticity Related to Any Cause Except Cerebral PalsyClinical Trials (1)
NCT04396704A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.
N/ABimanual 3D Motion Analysis " Be-API "
Unilateral Spastic Cerebral PalsyClinical Trials (1)
NCT03888443"Be an Airplane Pilot": A Bimanual 3D Motion Analysis in Children With Unilateral Cerebral Palsy
N/AStudy of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Tre
Neuroendocrine TumorsClinical Trials (1)
NCT07314164Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
N/ACommunity-based Neuroendocrine Tumor (NET) Research Study
Gastroenteropancreatic Neuroendocrine TumorsClinical Trials (1)
NCT02730104Community-based Neuroendocrine Tumor (NET) Research Study
N/AOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 1986
Portfolio: 9 approved products, 150 clinical trials
Top TAs: Oncology, Endocrinology, Neurology
Portfolio Health
Growth2 (22%)
Peak2 (22%)
LOE Approaching3 (33%)
Post-LOE2 (22%)
9 total products
Therapeutic Area Focus
Oncology
164 pipeline
Endocrinology
1 marketed42 pipeline
Neurology
1 marketed24 pipeline
Gastroenterology
17 pipeline
Nephrology
5 pipeline
Women's Health
5 pipeline
Metabolic Diseases
2 marketed2 pipeline
Rare Diseases
4 pipeline
Marketed
Pipeline
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles